News for MedPacto, Inc. (235980.KQ)

Published at

Sep 20, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Osteosarcoma Market to Grow Rapidly by 2032, Assesses DelveInsight | Leading Companies - MedPacto, Y-mAbs, QSAM, BioEclipse, Cellectar Biosciences, BioAtla, Salarius, Jazz, Fusion, Sumitomo Pharma Onc

The dynamics of the osteosarcoma market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising...

FUSN 235980.KQ INBX ESALY ESALF CLRB BCAB 4523.T SHPMY SHPMF IOVA 2607.HK 0JDK.L

Read more →
Published at

Mar 10, 2022 7:00 PM

by globenewswire.com

mixed

mixed

Adenoid Cystic Carcinoma Pipeline is Indicative of Many Opportunities Left For Research and Development, Analyzes DelveInsight

Adenoid Cystic Carcinoma is a rare and unique form of cancer that is known to be unpredictable in nature, with a typical growth pattern of being slow and...

CSPHF INCY I1NC34.SA DNPUF 4506.T 235980.KQ 0J9P.L

Read more →